Latest CNCE reports update at 2022-11-07: 2022-Q32022-Q22022-Q1
Concert Pharmaceuticals logo
Concert Pharmaceuticals CNCE
$ 8.37 0.0%

Concert Pharmaceuticals Deferred Revenue 2011-2024 | CNCE

Annual Deferred Revenue Concert Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 2.75 M 7.78 M 1.41 M 1.44 M 1.17 M 1.28 M 5.96 M 4.32 M - 6.89 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
7.78 M 1.17 M 3.67 M

Quarterly Deferred Revenue Concert Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - 1.41 M 7.78 M 7.78 M 7.78 M 7.78 M 7.78 M 1.41 M 1.41 M 1.41 M 1.41 M 1.44 M 1.39 M 1.17 M 1.16 M 1.17 M 1.17 M 1.17 M 1.17 M 1.28 M 1.28 M 1.28 M 1.28 M 5.96 M 5.96 M 5.96 M 5.96 M 4.32 M 4.32 M 4.32 M 4.32 M - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.78 M 1.16 M 3.4 M